<DOC>
	<DOCNO>NCT00654914</DOCNO>
	<brief_summary>The primary objective study ass efficacy together safety flexible regimen , period twelve week , three dos ( 5 mg , 10mg 20mg ) Bay 38-9456 , phosphodiesterase type V inhibitor , male erectile dysfunction treat sildenafil previous &lt; 6 month .At entry , Inclusion Exclusion criterion confirm , study medication administer twelve week open label design . Vardenafil administer , need , fix dose 10 mg daily first four week treatment . At Investigators ' discretion , basis efficacy safety evaluation , patient may , , receive dose strength assign study medication , subsequent clinic visit ( ) , next low dose ( 5 mg vardenafil ) next high dose ( 20 mg vardenafil ) subsequent four week treatment . Previous dose level vardenafil either maintain , increase decreased one step accord three applicable dose strength ( 5 mg , 10 mg , 20 mg ) . The high dosage vardenafil ( 20 mg ) per day exceed . After twelve week treatment , patient contact twenty four hour follow last visit order collect data concern serious adverse event .</brief_summary>
	<brief_title>A Study Assess Efficacy Safety Vardenafil Treatment Male Patients With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Males erectile dysfunction 6 month three year accord NIH Consensus definition ( inability achieve maintain penile erection sufficient satisfactory sexual intercourse ) Stable , heterosexual relationship 6 month Age range : 18 year older Documented , write Informed Consent . A ) Previous current Medical Conditions Any unstable medical psychiatric condition substance abuse disorder , opinion Investigator , likely affect patient 's ability complete study preclude patient 's participation study Presence penile anatomical abnormality ( e.g . penile fibrosis Peyronie disease ) would significantly impair erectile function . Primary hypoactive sexual desire Erectile dysfunction spinal cord injury Retinitis pigmentosa . History positive test Hepatitis B surface antigen ( HbsAg ) Hepatitis C. Unstable angina pectoris History myocardial infarction , stroke , electrocardiographic ischaemia ( except stable angina ) , lifethreatening arrhythmia , within prior 6 month . Atrial tachyarrhythmia ( e.g . atrial fibrillation/flutter ) heart rate &gt; 100 beat per minute screening Severe chronic liver disease liver function abnormality Clinically significant chronic haematological disease bleed disorder History significant peptic ulcer disease within one year Visit 1 . Resting hypotension ( rest systolic blood pressure &lt; 90 mm Hg ) hypertension ( rest systolic blood pressure &gt; 170 mm Hg rest diastolic blood pressure &gt; 110 mm Hg ) Symptomatic postural hypotension within six month Visit 1 . Uncontrolled diabetes mellitus ( Haemoglobin A1c &gt; 12 % ) History malignancy within past 5 year ( squamous basal cell skin cancer K prostatic ) . B ) Concomitant Medication 1 . Patients take nitrate nitric oxide donor ( e.g . molsidomine ) .2 . Patients take anticoagulant , exception antiplatelet agent . 3 . Patients take androgen ( e.g . testosterone ) , trazodone antiandrogens . 4 . Patients take follow potent inhibitor cytochrome P 450 3A4 : HIV protease inhibitor ritonavir indinavir , antimycotic agent itraconazole ketoconazole ( topical form allow ) . 5 . Patients receive investigational drug ( include placebo ) within 30 day Visit 1 . 6 . Use vardenafil ( BAY 389456 ) time prior study . C ) Abnormal Laboratory Values 1 . Patients serum total testosterone level &gt; 10 % low limit normal ( accord range specify responsible laboratory ) . 2 . Patients serum creatinine &gt; 2.5 mg/dL.D ) Other Exclusion Criteria 1 . Patients unwilling cease use vacuum device , intracavernosal injection , Viagra therapy erectile dysfunction entire course study . 2 . Known hypersensitivity component investigational medication 3 . Patients illiterate unable understand language questionnaires available . 4 . Patients unwilling unable complete patient diary card .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Sexual Dysfunction</keyword>
</DOC>